Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

Jean Bourhis, Y. Tao, Y. Pointreau et al.|Annals of Oncology|2019

Cited by 4